Last month, the Food and Drug Administration (FDA) approved Truvada as pre-exposure prophylaxis (PrEP) for adolescents at risk for HIV infection. FDA approval represents a critical step toward operationalizing PrEP for adolescents, especially young gay and bisexual men and LGBTQ youth of color, who stand to benefit from this effective HIV prevention tool. In 2016, […]
The right to privacy and confidentiality for health information is deeply rooted in American history and tradition and in federal and state law. People living with HIV also have special concerns in keeping their health information private. These individuals have long faced harassment, discrimination, and stigma from society because of their HIV infection, and they […]
Over the past two years, the O’Neill Institute has been working in partnership with NMAC to examine the status of biomedical HIV prevention research and implementation in the United States. The focus of this work has been to explore how to bring the promise of biomedical HIV prevention to all communities highly impacted by HIV […]
AIDSWatch 2018 is March 26 and 27. AIDSWatch is the nation’s largest annual constituent-based national HIV/AIDS advocacy event, bringing together hundreds of people living with HIV and their allies to meet with members of Congress and to educate them about the important issues at state for people living with HIV/AIDS in the United States. In […]
Signup for our mailing list and stay up to date on the latest happenings at The O’Neill Institute
Or sign up for our RSS Feed
The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.